Exploring emerging biomarkers and therapies for metaplastic breast cancer
Pooja Advani, MBBS, MD, Mayo Clinic, Jacksonville, FL, gives an overview of hypothesis-generating research on biomarkers and therapies for metaplastic breast cancer. While heterogeneity among subtypes like spindle cell and squamous was not explored, future work aims to define their unique features. This interview took place at the 2024 San Antonio Breast Cancer Symposium (SABCS) congress in San Antonio, TX. These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.
